| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
22,262 |
6,639 |
$3.81M |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
13,233 |
4,309 |
$1.26M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
8,709 |
7,596 |
$1.08M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
8,584 |
2,950 |
$1.00M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
7,591 |
7,044 |
$939K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
6,991 |
5,817 |
$653K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,470 |
1,305 |
$246K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,452 |
1,243 |
$237K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,116 |
1,756 |
$195K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,015 |
1,879 |
$174K |
| 36415 |
Collection of venous blood by venipuncture |
7,557 |
6,233 |
$157K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
579 |
500 |
$123K |
| 80053 |
Comprehensive metabolic panel |
13,377 |
10,661 |
$123K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
1,115 |
1,061 |
$110K |
| 92523 |
|
619 |
595 |
$89K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
6,949 |
5,323 |
$78K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
522 |
499 |
$67K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
230 |
208 |
$66K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
872 |
749 |
$64K |
| 97168 |
|
400 |
396 |
$64K |
| A9270 |
Non-covered item or service |
2,277 |
800 |
$62K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
4,459 |
4,169 |
$59K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
781 |
554 |
$58K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
16,624 |
13,194 |
$53K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,133 |
2,024 |
$51K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,905 |
2,338 |
$44K |
| 81001 |
|
7,754 |
6,543 |
$37K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,802 |
1,607 |
$32K |
| 71045 |
Radiologic examination, chest; single view |
4,044 |
3,511 |
$30K |
| 97161 |
|
151 |
143 |
$30K |
| 87653 |
|
1,233 |
1,164 |
$29K |
| 71046 |
Radiologic examination, chest; 2 views |
2,635 |
2,396 |
$29K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,145 |
2,005 |
$27K |
| 81003 |
|
3,145 |
2,703 |
$27K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
5,935 |
4,903 |
$27K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,206 |
1,959 |
$27K |
| 87634 |
|
1,264 |
1,211 |
$26K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
617 |
558 |
$25K |
| 97165 |
|
155 |
150 |
$25K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
359 |
266 |
$24K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,495 |
2,847 |
$22K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,849 |
1,537 |
$22K |
| 84484 |
|
2,862 |
2,122 |
$22K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
4,611 |
3,507 |
$21K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
2,792 |
2,050 |
$21K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
1,624 |
1,424 |
$21K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
948 |
803 |
$20K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
796 |
615 |
$20K |
| 83735 |
|
3,273 |
2,519 |
$18K |
| J2704 |
Injection, propofol, 10 mg |
2,157 |
1,924 |
$17K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
3,101 |
2,058 |
$17K |
| 76801 |
|
678 |
554 |
$16K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
151 |
145 |
$14K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
327 |
308 |
$14K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
119 |
109 |
$14K |
| 82962 |
|
1,249 |
834 |
$13K |
| 86762 |
|
370 |
344 |
$12K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,113 |
1,846 |
$12K |
| 87070 |
|
239 |
223 |
$12K |
| 85027 |
|
1,494 |
1,230 |
$11K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,416 |
2,169 |
$11K |
| 83690 |
|
4,199 |
3,540 |
$11K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,788 |
3,331 |
$11K |
| 86850 |
|
1,266 |
1,102 |
$11K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,642 |
2,398 |
$10K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
49 |
43 |
$10K |
| 96376 |
|
1,602 |
1,136 |
$10K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,824 |
1,663 |
$10K |
| 85610 |
|
1,393 |
1,132 |
$10K |
| 01999 |
|
1,926 |
1,675 |
$10K |
| 84703 |
|
3,097 |
2,753 |
$10K |
| 86900 |
|
2,353 |
2,017 |
$9K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,257 |
998 |
$9K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,731 |
3,236 |
$9K |
| 83880 |
|
1,302 |
1,063 |
$8K |
| 97164 |
|
68 |
66 |
$8K |
| 86140 |
|
2,600 |
2,287 |
$8K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,214 |
1,118 |
$8K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,803 |
1,653 |
$8K |
| 84439 |
|
643 |
592 |
$8K |
| G0378 |
Hospital observation service, per hour |
331 |
171 |
$8K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,596 |
1,393 |
$8K |
| 87077 |
|
1,570 |
1,396 |
$6K |
| 97162 |
|
46 |
39 |
$6K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
28 |
26 |
$6K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
450 |
368 |
$6K |
| 86901 |
|
2,351 |
2,018 |
$6K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
711 |
629 |
$5K |
| 92526 |
|
139 |
72 |
$5K |
| J3490 |
Unclassified drugs |
219 |
142 |
$4K |
| 80061 |
Lipid panel |
1,238 |
1,095 |
$4K |
| 87040 |
|
802 |
692 |
$4K |
| 83605 |
|
586 |
474 |
$4K |
| 87186 |
|
920 |
820 |
$4K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,321 |
1,074 |
$4K |
| 84702 |
|
1,444 |
1,067 |
$4K |
| 82728 |
|
193 |
178 |
$3K |
| 80076 |
|
409 |
366 |
$3K |
| 85730 |
|
646 |
558 |
$3K |
| 73610 |
|
44 |
38 |
$2K |
| 93971 |
|
30 |
25 |
$2K |
| 86803 |
|
775 |
705 |
$2K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
26 |
26 |
$2K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
565 |
504 |
$2K |
| 99234 |
|
59 |
26 |
$2K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
47 |
38 |
$2K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
588 |
419 |
$2K |
| 76641 |
|
40 |
32 |
$1K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
718 |
659 |
$1K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
282 |
227 |
$1K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
64 |
60 |
$1K |
| 82950 |
|
462 |
445 |
$1K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
64 |
60 |
$1K |
| 87340 |
|
630 |
574 |
$1K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
54 |
26 |
$1K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
46 |
41 |
$1K |
| 87486 |
|
30 |
28 |
$1K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
79 |
71 |
$1K |
| 74018 |
|
59 |
54 |
$905.37 |
| 83540 |
|
258 |
239 |
$897.70 |
| 85379 |
|
399 |
351 |
$848.13 |
| 82570 |
|
1,023 |
770 |
$842.34 |
| 85652 |
|
586 |
508 |
$827.68 |
| 82607 |
|
137 |
125 |
$706.19 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
179 |
161 |
$667.11 |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
42 |
38 |
$646.63 |
| 73630 |
|
70 |
65 |
$589.55 |
| 84156 |
|
859 |
613 |
$505.21 |
| 76830 |
Ultrasound, transvaginal |
15 |
12 |
$454.93 |
| P9604 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge |
381 |
217 |
$435.18 |
| 84112 |
|
29 |
24 |
$364.22 |
| 82565 |
|
58 |
43 |
$358.40 |
| 73030 |
|
14 |
12 |
$258.75 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
203 |
139 |
$234.23 |
| 84550 |
|
660 |
503 |
$229.97 |
| 83615 |
|
670 |
513 |
$225.60 |
| 82550 |
|
50 |
37 |
$223.70 |
| 87210 |
|
732 |
676 |
$216.07 |
| 84466 |
|
136 |
130 |
$123.31 |
| 86592 |
|
734 |
668 |
$117.07 |
| 87581 |
|
30 |
28 |
$51.13 |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
30 |
28 |
$51.13 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
941 |
910 |
$50.48 |
| 84450 |
|
52 |
39 |
$25.71 |
| 84460 |
|
50 |
37 |
$25.71 |
| 73564 |
|
32 |
25 |
$25.13 |
| 82746 |
|
32 |
27 |
$17.24 |
| 84520 |
|
43 |
29 |
$13.80 |
| 83550 |
|
124 |
118 |
$0.00 |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
13 |
13 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
70 |
58 |
$0.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
82 |
70 |
$0.00 |
| D9420 |
|
88 |
87 |
$0.00 |
| 3044F |
|
61 |
59 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
79 |
67 |
$0.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
51 |
39 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
125 |
111 |
$0.00 |
| 81025 |
|
19 |
18 |
$0.00 |